Visa’s board of directors is advising shareholders to reject a new policy proposal that calls for the company to address a perceived gap in health insurance coverage for individuals seeking to detransition following gender transition procedures.
The proposal, titled “Gender-Based Compensation Gaps and Associated Risks,” is being spearheaded by the National Legal and Policy Center (NLPC) and will be presented at Visa’s annual shareholder meeting.
The NLPC’s proposal suggests that Visa could face legal challenges if it does not offer insurance coverage for those seeking to reverse or halt the effects of medical interventions designed to alter their appearance to resemble the opposite sex.
Currently, Visa’s insurance plans cover treatments for employees and dependents experiencing gender dysphoria who wish to transition. However, there is no specific coverage for those experiencing complications from these procedures who wish to detransition.
The proposal highlights that Visa provides benefits for employees and their children who suffer from gender dysphoria, offering medical, chemical, and surgical treatments to assist in their transition.
Critics argue that the absence of similar support for detransitioners represents a significant oversight in Visa’s employee benefits program.
Visa’s board has expressed opposition to the proposal, urging shareholders to vote against it. According to a proxy statement, the board believes that the requested report is unnecessary and not in the best interest of shareholders, asserting that the company already has appropriate initiatives and benefits in place to support its global workforce.
When asked for comments, a Visa spokesperson referred the Daily Caller News Foundation (DCNF) to the proxy statement.
The NLPC is also calling on Visa to produce a report detailing the benefits and gaps in health programs related to gender dysphoria and detransitioning care.
The proposal outlines several potential harms associated with medical sex change interventions, noting that individuals often report negative side effects such as chronic pain, sexual dysfunction, and other complications.
Many detransitioners struggle to find adequate medical or insurance coverage, leading some to pursue legal action against those they believe have harmed them.
Claire Abernathy, a 20-year-old detransitioner, is expected to share her personal experience in support of the proposal at the shareholder meeting. Abernathy began transitioning as a young teenager, undergoing testosterone treatment and a double mastectomy by age 14, only to later experience irreversible consequences and difficulty accessing medical support to address her situation.
Paul Chesser, director of the Corporate Integrity Project at the NLPC, emphasized the potential legal liabilities for corporations like Visa that finance gender-transition procedures for minors. He warned that these companies might face lawsuits from individuals harmed by such interventions.
Visa’s current insurance offerings for cosmetic sex change procedures, which include hormone therapy and surgeries such as vaginoplasty and mastectomy, are aligned with standards set by the World Professional Association of Transgender Health (WPATH).
This organization has faced controversy for its recommendations, which include providing sterilizing drugs and irreversible surgeries to gender dysphoric children.
3 Comments
RINO Lindsay needs to review the videos of the capital police removing barriers added and opening doors to the protestors and then opening up their ambush!
He is evil! He knows all of that and more! I say this evil backstabbing Judas SOB Graham deserves Hell, but First GITMO! Traitor to the Nth Degree!
Holy JesUS what a mess they are making of these young transitional transgenders that are created in your image! IF anything they need mental health therapy!